<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">26873596</PMID>
        <DateCompleted>
            <Year>2017</Year>
            <Month>04</Month>
            <Day>25</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1433-8726</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>34</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2016</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>World journal of urology</Title>
                <ISOAbbreviation>World J Urol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Intermediate-term cancer control outcomes in prostate cancer patients treated with robotic-assisted laparoscopic radical prostatectomy: a multi-institutional analysis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1357-66</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00345-016-1781-y</ELocationID>
            <Abstract>
                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Cancer control outcomes following robot-assisted radical prostatectomy (RARP) for prostate cancer (PCa) remain inadequately addressed over intermediate-term (≥5-year) follow-up. We examined biochemical recurrence-free survival (BCRFS), clinical recurrence-free survival (CRFS), and cancer-specific survival (CSS) in a multi-institutional cohort of men undergoing RARP for localized PCa.</AbstractText>
                <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">A total of 5670 PCa patients undergoing RARP ± pelvic lymph node dissection as primary treatment modality at three tertiary care centers between 2001 and 2010 were analyzed. BCRFS, CRFS, and CSS were estimated using the Kaplan-Meier method. Cox proportional hazards model tested their association with available preoperative and postoperative parameters.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">43.6 and 15.1 % of patients had D'Amico intermediate- and high-risk disease, respectively. Over a mean (median) follow-up of 56 (50.4) months, 797 men had a BCR, 78 men had CR, and 32 men died of PCa. Actuarial BCRFS, CRFS, and CSS, respectively, were 83.3, 98.6, and 99.5 % at 5-year; 76.5, 97.5, and 98.7 % at 8-year; and 73.3, 96.7, and 98.4 % at 10-year follow-ups. Only 1.7 % of patients received any adjuvant treatment. Preoperative prostate-specific antigen (PSA) and biopsy Gleason score (GS) were independent clinical predictors of BCRFS, CRFS, and CSS, while postoperatively positive surgical margin, pathological GS, pathological stage, and lymph node invasion were significantly associated with BCR and CR (all p &lt; 0.05).</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Cancer control outcomes of RARP appear comparable to those reported for open and laparoscopic RP in previous literature, despite low overall rate of adjuvant treatment. Disease severity and preoperative PSA may aid in risk prognostication and defining postoperative follow-up protocols.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Abdollah</LastName>
                    <ForeName>Firas</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vattikuti Urology Institute and VUI Center for Outcomes Research Analytics and Evaluation (VCORE), Henry Ford Hospital, Henry Ford Health System, 2799 W Grand Blvd, Detroit, MI, 48202-2689, USA. firas.abdollah@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dalela</LastName>
                    <ForeName>Deepansh</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vattikuti Urology Institute and VUI Center for Outcomes Research Analytics and Evaluation (VCORE), Henry Ford Hospital, Henry Ford Health System, 2799 W Grand Blvd, Detroit, MI, 48202-2689, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sood</LastName>
                    <ForeName>Akshay</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vattikuti Urology Institute and VUI Center for Outcomes Research Analytics and Evaluation (VCORE), Henry Ford Hospital, Henry Ford Health System, 2799 W Grand Blvd, Detroit, MI, 48202-2689, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sammon</LastName>
                    <ForeName>Jesse</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vattikuti Urology Institute and VUI Center for Outcomes Research Analytics and Evaluation (VCORE), Henry Ford Hospital, Henry Ford Health System, 2799 W Grand Blvd, Detroit, MI, 48202-2689, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jeong</LastName>
                    <ForeName>Wooju</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vattikuti Urology Institute and VUI Center for Outcomes Research Analytics and Evaluation (VCORE), Henry Ford Hospital, Henry Ford Health System, 2799 W Grand Blvd, Detroit, MI, 48202-2689, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Beyer</LastName>
                    <ForeName>Burkhard</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fossati</LastName>
                    <ForeName>Nicola</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Urology, Vita Salute San Raffaele University, Milan, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rogers</LastName>
                    <ForeName>Craig G</ForeName>
                    <Initials>CG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vattikuti Urology Institute and VUI Center for Outcomes Research Analytics and Evaluation (VCORE), Henry Ford Hospital, Henry Ford Health System, 2799 W Grand Blvd, Detroit, MI, 48202-2689, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Diaz-Insua</LastName>
                    <ForeName>Mireya</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vattikuti Urology Institute and VUI Center for Outcomes Research Analytics and Evaluation (VCORE), Henry Ford Hospital, Henry Ford Health System, 2799 W Grand Blvd, Detroit, MI, 48202-2689, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Peabody</LastName>
                    <ForeName>James</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vattikuti Urology Institute and VUI Center for Outcomes Research Analytics and Evaluation (VCORE), Henry Ford Hospital, Henry Ford Health System, 2799 W Grand Blvd, Detroit, MI, 48202-2689, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Haese</LastName>
                    <ForeName>Alexander</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Montorsi</LastName>
                    <ForeName>Francesco</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Urology, Vita Salute San Raffaele University, Milan, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Graefen</LastName>
                    <ForeName>Markus</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Briganti</LastName>
                    <ForeName>Alberto</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Urology, Vita Salute San Raffaele University, Milan, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Menon</LastName>
                    <ForeName>Mani</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vattikuti Urology Institute and VUI Center for Outcomes Research Analytics and Evaluation (VCORE), Henry Ford Hospital, Henry Ford Health System, 2799 W Grand Blvd, Detroit, MI, 48202-2689, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016448">Multicenter Study</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2016</Year>
                <Month>02</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>World J Urol</MedlineTA>
            <NlmUniqueID>8307716</NlmUniqueID>
            <ISSNLinking>0724-4983</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D060787" MajorTopicYN="N">Neoplasm Grading</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011468" MajorTopicYN="N">Prostatectomy</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011471" MajorTopicYN="N">Prostatic Neoplasms</DescriptorName>
                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
                <QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName>
                <QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012371" MajorTopicYN="N">Robotics</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName>
                <QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014481" MajorTopicYN="N">United States</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Biochemical recurrence</Keyword>
            <Keyword MajorTopicYN="Y">Clinical recurrence</Keyword>
            <Keyword MajorTopicYN="Y">Intermediate-term follow-up</Keyword>
            <Keyword MajorTopicYN="Y">Prostate cancer</Keyword>
            <Keyword MajorTopicYN="Y">Robot-assisted radical prostatectomy</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2015</Year>
                <Month>11</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2016</Year>
                <Month>02</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>2</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>2</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>4</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">26873596</ArticleId>
            <ArticleId IdType="doi">10.1007/s00345-016-1781-y</ArticleId>
            <ArticleId IdType="pii">10.1007/s00345-016-1781-y</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Eur Urol. 2014 May;65(5):918-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23721959</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Urol. 2009 May;55(5):1014-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19013010</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Endourol. 2012 Dec;26(12):1558-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23230869</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BJU Int. 2009 Sep;104(6):813-7; discussion 817-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19254280</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Urol. 2003 Jun;169(6):2289-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12771773</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Urol Clin North Am. 2001 Aug;28(3):555-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11590814</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Urol. 2012 Apr;61(4):679-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22206800</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BJU Int. 2013 Aug;112(4):E314-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23451984</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Urology. 2012 Mar;79(3):626-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22245303</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Urol. 2000 Apr;163(4):1155-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10737486</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Urol. 2012 Jul;62(1):1-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22405509</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Urol. 2010 Dec;58(6):838-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20869162</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):788-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19818565</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Urol. 2002 Sep;168(3):945-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12187196</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Urol. 2004 Sep;172(3):910-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15310996</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BJU Int. 2007 Sep;100(3):528-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17573893</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2015 Mar 10;33(8):944-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25667284</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25559415</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Urol. 2009 Mar;181(3):956-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19167731</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Urol. 2012 Dec;188(6):2205-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23083657</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Urol. 2014 Jul;66(1):138-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24411279</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BJU Int. 2006 Dec;98(6):1204-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17034506</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2012 Dec 8;380(9858):2018-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23084481</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Urol. 2013 Jun;63(6):998-1008</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23122664</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Urol. 2011 Jan;185(1):116-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21074194</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Urol. 2012 Sep;62(3):382-404</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22749851</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Urol. 2012 Nov;62(5):768-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22633365</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Urology. 2012 Jan;79(1):133-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22088567</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Urol. 2015 Jun;67(6):1168-1176</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24996687</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BJU Int. 2012 Dec;110(11 Pt C):E985-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22672442</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BJU Int. 2014 Dec;114(6):955-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24238369</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 1998 Sep 16;280(11):969-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9749478</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>